Neetour Medical

Company Overview

Snapshot

Founded in September 2010 by Ofer Hornick, MD, Neetour Medical operated with 1–10 employees. The company developed Capno-Pulse, a noninvasive technology for monitoring blood CO2 levels, and was selected to be part of the Samsung Mobile SimBand wearable project.

Business overview

Neetour Medical specializes in developing noninvasive technologies for monitoring carbon dioxide (CO2) levels in the blood. Its core product, Capno-Pulse, utilizes photoplethysmography (PPG) through infrared and visible light sensors to analyze blood volume changes, providing CO2 trends applicable across well-being, sports, and healthcare sectors. The company operates within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Patient Remote Monitoring, serving global markets with a focus on B2G, B2B, and B2C business models.

Company Intelligence Q&A

What is Neetour Medical's core technology?

Neetour Medical developed Capno-Pulse, a noninvasive technology that monitors carbon dioxide (CO2) levels in the blood. This system analyzes photoplethysmography (PPG) data, which measures blood volume changes using infrared and visible light sensors.

Which markets does Neetour Medical serve?

Neetour Medical's technology is designed for a wide range of applications in well-being, sports, and healthcare. The company targets global markets with business models including B2G, B2B, and B2C.

What significant partnership did Neetour Medical engage in?

Neetour Medical's technology was selected to be integrated into the Samsung Mobile SimBand wearable project. This platform aimed to continuously gather vital diagnostic information for lifestyle, medical, and sports-related applications.

When was Neetour Medical founded?

Neetour Medical was founded in September 2010 by Ofer Hornick, MD.

What is the operational status of Neetour Medical?

Neetour Medical is currently non-active and ceased to operate in December 2019.